Wednesday, September 28, 2022 | Back issues
Courthouse News Service Courthouse News Service

Cancer Drug

TRENTON, N.J. - Providence, R.I., claims Celgene Corp. is illegally preventing introduction of generic forms of the blockbuster cancer drugs Thalidomide and its Revlimid analogue, in a federal antitrust complaint.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...